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PML: Still Relevant in the ART Era
Amit Vahia MD MPH and Indira Brar MD
Division of Infectious Diseases
Henry Ford Health System, Detroit, Michigan
Introduction
PML is a demyelinating disease caused by reactivation
of the polyomavirus JC
Asymptomatically acquired in childhood with positive
antibodies in 86% adults.
Lies dormant in the kidney and lymphoid tissue.
With profound IS, reactivation occurs with spread to
CNS and demyelinating disease of oligodendrocytes.
Since the widespread use of combined ART, the
incidence of PML in patients with HIV infection has
decreased . In a population-based study from Denmark
involving a nationwide cohort of patients aged 16 and
older with HIV infection, the incidence of PML declined
from 3.3 cases/1000 patient years at risk to 1.1
cases/1000 patient years at risk.1

Progressive Multifocal Leukoencephalopathy is a rare,
often fatal demyelinating neurological disease seen in
profoundly immunocompromised patients. It is caused
by reactivation of JC Virus.

Associated with 20 lb. weight loss over the same period
Denied any other infectious symptoms of fever, chills,
nausea, vomiting, diarrhea, rash, joint pain, URI
symptoms, dysuria, genital lesions or other problems. He
denied sick contacts or recent travel or occupational
exposure.

Admitted to sexual promiscuity with high risk female
partners in years past

Physical Examination
• BP 129/93, RR 18, Pulse 77, Temp 36.7
• BMI 17.9
• Diminished muscle bulk

•
•
•
•

HIV positive 4th generation testing.
CD4 count 35
HIV Viral load 500,000
CSF JC Virus PCR: Positive

Types of PML

The diagnosis is made by CSF PCR for Polyomavirus
JC. The test is 72-92% sensitive and 92-100% specific
2
for the disease. Treatment is aimed toward correcting
the patient’s underlying immunodeficiency.

Classical
• Variable neurological deficits patient to patient.
Ataxia, hemianopia, weakness
• T cell count less than 200
Inflammatory
• Paradoxical unmasking of PML due to IRIS
• Better prognosis than classical
JC virus cerebellar granule cell neuronopathy
• Ataxia and cerebellar atrophy
• Mutations in the structure of the JC virus VP1 capsid

History of Present Illness
A 33 year old gentleman presented to Henry Ford
Hospital in November 2018 with lower extremity
weakness, fatigue, and progressive difficulty with
activities of daily living over the last 2-3 weeks with
multiple falls at home.

Lab Findings

MRI Brain: Demonstrates a large
lesion in the left cerebellar
hemisphere. The lesion
demonstrates low signal
intensity on T1, high signal
intensity on T2/FLAIR, without
diffusion restriction or
enhancement. Companion
lesions in the right parietal and
left frontal lobes have
predilection for the cerebral
cortex white matter.

JC virus meningitis: More typical headache,
photophobia, nuchal rigidity presentation.

JC virus encephalopathy: Rarely described, but rapidly
fatal

Treatment
• Correct the underlying immunodeficiency by starting
ART in AIDS patients.
• Remove offending drugs for those patients exposed
to notorious immunomodulator therapies like
natalizumab in Multiple Sclerosis.
• Plasma exchange and steroids have been used to
varied but unreliable success.
• Investigational therapies including cytarabine,
cidofovir, topotecan, mirtazapine, mefloquine,
maraviroc have been tried unsuccessfully.
• Outcome is often fatal and if not, leaves patients with
significant neurological deficits. Our patient
succumbed to his illness 1 month after presentation.

• Dysdiadokokinesia and dysmetria on right hand
• Preserved mental status
• Slowed speech and movement.
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